Revenue and Profit - Revenue for Q1 2016 was CNY 58,968,046.44, an increase of 25.50% compared to CNY 46,987,464.09 in the same period last year[8] - Net profit attributable to shareholders was CNY -955,222.59, a decrease of 109.46% from CNY 10,098,042.27 year-on-year[8] - The company reported a basic earnings per share of CNY -0.0009, a decrease of 109.18% from CNY 0.0098 in the previous year[8] - The company anticipates potential losses or significant changes in net profit compared to the same period last year, but no specific guidance was provided[18] Cash Flow and Operating Activities - Net cash flow from operating activities reached CNY 45,122,041.38, a significant increase of 5,997.11% compared to CNY 740,056.43 in the previous year[8] - Cash received from tax refunds soared by 12049.45% to ¥73,075.28, as the parent company received export tax rebates[15] - The company reported a significant increase in sales expenses, which rose by 429.39% to ¥10,516,946.99, due to higher costs incurred by Beijing Sihuan[15] Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,025,800,890.10, up 22.92% from CNY 834,527,725.13 at the end of the previous year[8] - Net assets attributable to shareholders were CNY 605,666,874.37, a slight decrease of 0.16% from CNY 606,622,096.96 at the end of the previous year[8] - Short-term borrowings decreased by 71.43% to ¥10,000,000.00 as Jiangsu Sihuan Biopharmaceutical repaid ¥35,000,000.00 of debt[15] - Accounts payable surged by 224.15% to ¥273,148,190.42, driven by new seedling procurement payments for the Chenwei Ecological Park[15] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 106,665[11] - The largest shareholder, Kunshan Chuangye Investment Co., Ltd., held 7.06% of the shares, totaling 72,671,714 shares[11] Inventory and Intangible Assets - Inventory increased by 89.34% to ¥401,294,285.72 due to new seedling purchases for the Chenwei Ecological Park project[15] - Intangible assets rose by 32.05% to ¥78,047,977.28, attributed to the acquisition of non-patented technology by Beijing Sihuan[15] Investment Activities - Investment activities resulted in a net cash outflow of ¥23,585,862.84, reflecting new intangible asset purchases[15] Return on Equity - The weighted average return on equity was -0.16%, down 1.39% from 1.23% in the same period last year[8]
四环生物(000518) - 2016 Q1 - 季度财报